ADAR and mesothelioma: The destabilization of dsRNA structures upon ADAR activity suppresses the cellular response to dsRNA by preventing type‐1 IFN signaling, and the TCGA study [6] has revealed that in mesothelioma this activation occurs in tumors with mutated BAP1.